Which statement is the scientific rationale for prescribing atomoxetine (Strattera), a norepinephrine reuptake inhibitor, for a child diagnosed with attention deficit– hyperactivity disorder (ADHD)?...

Which statement is the scientific rationale for prescribing atomoxetine (Strattera), a norepinephrine reuptake inhibitor, for a child diagnosed with attention deficit– hyperactivity disorder (ADHD)?

1. It increases acetylcholine levels and the brain’s cholinergic function.

2. This medication normalizes the reuptake of certain neurotransmitters.

3. This medication is a nonstimulant, nonnarcotic that regulates impulse control.

4. It results in mild central nervous stimulation to control the child’s behavior.